Wednesday 28 June 2017

Vascular Graft Market Size Is Projected To Be Around $4.2 Billion By 2025: Crystal Market Research



A research study titled, “Vascular Graft Market by Product, Application, and Raw Material - Global Industry Analysis and Forecast to 2025” published by Crystal Market Research, states that the vascular graft market is projected to be around $4.2 billion by 2025.

Vascular grafts are prosthetic implants that are used to replace, repair or bypass sections of blood vessels. As the need for coronary vascularization is increasing worldwide, different strategies have been investigated for blood restoration to the heart. Vascular grafts are being evaluated for the bypass surgery of the atherosclerotic coronary arteries. Cardiovascular diseases (CVDs) such as atherosclerosis can be treated by implantation of vascular grafts with the help of coronary artery bypass surgery. CVD is a class of diseases which affects heart or blood vessels. CVDs include stroke, heart failure, congenital heart disease, angina, arrhythmia and myocardial infarction. The risk factors for CVDs are high blood pressure, obesity, unhealthy diet, and physical inactivity, tobacco consumption, drinking excess alcohol, smoking, aging, high blood cholesterol, stress, and depression. CVDs are characterized by chest pain, tiredness, increasing heartbeat, excessive sweating and difficulty in breathing. According to a study conducted by American Heart Association in 2017, around 92.1 million American adults have some or the other type of CVD. The study further states that the estimated number of annual new heart attacks in U.S. is 580,000 with 210,000 incidences of recurrent attacks. Suchhigh prevalence of CVDs will drive the global market during forecast period.

Browse full research report with TOC on “Vascular Graft Market by Product, Application, and Raw Material - Global Industry Analysis and Forecast to 2025” at: http://www.crystalmarketresearch.com/report/vascular-graft-market

Endovascular stent grafts segment occupied the largest share of the overall market in 2016, due to factors such as decrease in the level of physical activity, increase in the consumption of junk food, tobacco and alcohol. Cardiovascular diseases segmentaccounted for the largest share of the global market in 2016,owing toincrease in the pervasiveness of hypertension and increase in risk factors such as high blood sugar and other age related disorders. Polyester based grafts segment accounted for the major share of the overall market in 2016, due to factors such as excessive tensile strength, raw material availability and durability. Biological materials segment is expected to witness fastest growth during forecast period owing to high adoption rate among users and increase demand for more biocompatible vascular grafts.

U.S. occupied the largest share of the North America vascular graft market in 2016, due to factors such as increase in the healthcare expenditure, advancement in healthcare facilities and high prevalence of cardiovascular disorders. Furthermore, increasing adoption of technologically advanced products will drive the U.S. market during the forecast period. Emerging markets such as China and India arepoised to witness favorable growth during the forecast period due to factors such as rise in geriatric population andcontinuous improvement in healthcare infrastructure. Furthermore, government initiatives in India such as “Make in India” encourages many players to set up manufacturing plants in thecountry, which is set to stimulate the market growth during forecast period.

Request a sample copy of Vascular Graft Market Research Report at: http://www.crystalmarketresearch.com/report-sample/HC0634

Product development is the major strategy adopted by the key players to sustain the market competition. For instance, in December 2016, Medtronic obtained CE Mark for its Endurant II/IIs stent graft system for treating abdominal aortic aneurysm patients.

Some of the key players in vascular graft market are W.L. Gore & Associates, Inc., Terumo Medical Corporation, B. Braun Melsungen AG, Vascutek Ltd, Shanghai Suokang Medical Implants Co., Ltd, Medtronic Plc., Artegraft, LeMaitre Vascular Inc., MAQUET Holding B.V. & Co. KG,Heart Medical Europe BV, Bard Peripheral Vascular Inc., and Cook Medical Group.


Key Findings of the Research Study:

·         Endovascular stent grafts segment accounted for three-fourth share of the global market in 2016, owing to their wide adoption in treating aortic disorders caused due to diabetes and cardiovascular devices.

·         Hemodialysis segment is expected to witness high growth during forecast period owing to increasing prevalence of diabetic people suffering from kidney related disorders.

·         Cardiovascular diseases segment accounted for one-fourth share of the global market in 2016 owing to rise in incidences of hypertension, aneurysm, and other age-related disorders.

·         Polyester based vascular graft segment held over one-third market share in 2016. High durability and tensile strength and easy availability of these grafts will further contribute to the growth of this segment.

·         North America accounted for almost half of the market share in 2016, owing to presence of large elderly population suffering from cardiovascular and other disorders.

·         Asia-Pacific is expected to grow at fastest CAGR owing to rise in disposable income of people and increase in demand for better healthcare infrastructure.

Related Reports: 

Interventional Cardiology & Peripheral Vascular Devices Market by Product - Global Industry Analysis and Forecast to 2025:http://www.crystalmarketresearch.com/report/interventional-cardiology-peripheral-vascular-devices-market

Bone Grafts and Substitutes Market by Material and Application - Global Industry Analysis and Forecast to 2025:http://www.crystalmarketresearch.com/report/bone-grafts-and-substitutes-market

Dental Bone Graft Substitutes Market by Type, Application, and Product - Global Industry Analysis and Forecast to 2025:http://www.crystalmarketresearch.com/report/dental-bone-graft-substitutes-market

Soft Tissue Repair Market by Product and Application - Global Industry Analysis and Forecast to 2025:http://www.crystalmarketresearch.com/report/orthopedic-soft-tissue-repair-market

Vascular Graft Market Segmentation:

By Product:
  • Hemodialysis Access Graft
  • Peripheral Vascular Graft
  • Endovascular Stent Graft
  • Coronary Artery By-pass Graft
By Application:
  • Cardiovascular Diseases
o    Coronary Artery Disease
o    Hypertension
o    Cardiac Stroke
o    Cardiac Aneurysm
  • Kidney Failure
  • Vascular Occlusion
  • Aneurysm
  • Diabetes
By Raw Material:
  • Polytetrafluoroethylene based Vascular Graft
  • Polyester based Vascular Graft
  • Polyurethane based Vascular Graft
  • Biological Materials based Vascular Graft
o    Human Saphenous and Umbilical Veins
o    Tissue Engineered Materials
By Region:
  • North America
o    U.S
o    Canada
o    Mexico
  • Europe
o    Germany
o    France
o    UK
o    Italy
o    Spain
o    Rest of Europe
  • Asia-Pacific
o    Japan
o    China
o    Australia
o    India
o    South Korea
o    Rest of Asia-Pacific
  • Rest of the World
o    Brazil
o    South Africa
o    Saudi Arabia
o    Turkey
o    United Arab Emirates
o    Others

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:
Akhil V.
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282

Biosimulation market Size is projected to be around $4 billion by 2025: Crystal Market Research



A research study titled, “Biosimulation Market by Product, Application, and End User - Global Industry Analysis and Forecast to 2025” published by Crystal Market Research, states that the biosimulation market is projected to be around $4 billion by 2025.

A typical drug discovery and development cycle, which encompasses the time taken for discovery of a new drug and its delivery to the market, may easily take up to 10 to 15 years. The process of drug discovery which starts with discovering a new drug molecule to registering the drug for marketing and commercialization is a very lengthy and complex process. Heavy capital investment, considerable amount of time and series of clinical trials are required before a drug is registered for human use. FDA launched the Critical Path Initiative (CPI), in 2004, to promote innovation in scientific processes by which medical products are developed, examined and manufactured.

Biosimulation is one such promising notion to drug discovery and development. It has been developed in order to avoid the hurdles in discovery and development of a new drug by traditional processes. It promises tremendous benefits saving both money and time and improves the predictability in early stage of the drug development. In biosimulation, the relationships between different biological elements are represented using differential equations utilizing simulation techniques to predict the behavior of the biological system and status of biological elements over time.

Browse full research report with TOC on “Biosimulation Market by Product, Application, and End User - Global Industry Analysis and Forecast to 2025” at:http://www.crystalmarketresearch.com/report/biosimulation-market

Rise in cases of chronic diseases such as diabetes, high drug resistance exhibited by certain disease related pathogens, and rapidly aging population worldwide are some of the factors encouraging biosimulation market. Moreover, high drug failure rate and availability of advanced modeling and simulation tools will further contribute to the market growth.
In 2016, the software segment accounted for over half of the global market,due to the high accuracy of computer modeling in biosimulation to improve drug molecules. In terms of applications, the drug discovery marketis expected to show an impressive growth rate over the forecast period due to the benefits of biosimulation processesin assisting the researchers in identifying critical gaps that hamper the drug discovery process.

Pharmaceutical and biotechnology companiessegment held more than half of the global market in 2016. This large share can be attributed to the rising acceptance of in silico models (biological experiments performed entirely by means of a computer) for drug discovery and development. Large numbers of pharmaceutical and biotechnology companies are aggressively using computer models to create more advanced and effective drug variants. For example, in January 2017, Certara, the global biosimulation drug development company, announced the release of version 16 of its Simcyp Population-based Simulator, which is one of the most sophisticated platforms to determine first in-human dose selection.

Request a sample copy of Biosimulation Market Research Report at: http://www.crystalmarketresearch.com/report-sample/HC0637

U.S. accounted for the major share of the North American market in 2016, due to the high prevalence of chronic diseases, rapidly growing elderly population, which is more prone to these diseases and are in need of treatment options such as drugs, and strategic collaborations among leading players. For instance, Certara in September 2016 acquired Australia based d3 Medicine to strengthen their ability to deliver optimized drug development plans to their clients.Also, there is rise in research activities on biosimulation in the region which will facilitate the market growth. For instance, in April 2016, Certara launched an e-learning platform under Certara University to facilitate education in the field of biosimulation and model based drug development. Emerging economies in Asia-Pacific biosimulation market will exhibit the fastest growth in the forecast period due to emphasis on research and development initiatives and rising focus of international playerson the emerging markets. For instance, in January 2016, Certara launched a strategic drug development consulting company in China, named, Certara Strategic Consulting.

The competitive market for biosimulation is driven by strategic collaborations and acquisitions by leading players to strengthen their research and development capabilities and to expand their existing product portfolio. For instance, in late December 2015, Certaraacquired XenologiQ, a UK based quantitative systems pharmacology (QSP) firm, to strengthen its modeling and simulation capabilities. Some of the leading players in biosimulation market are, Certara USA, Inc., DassaultSystèmesSA, Accelrys, Compugen, Rhenovia Pharma, Leadscope Inc., Simulations Plus, Inc. and Evidera, Inc.

Key Findings of the Research Study:
·         The biosimulation market will be majorly driven by rise in chronic disease incidence such as cancer and diabetes, increasing prevalence of geriatric population, high drug resistance by certain disease related pathogens and high drug failure rate.
·         The services segment will exhibit favorable growth over the forecast period as more and more pharmaceutical companies are beginning to outsource their biosimulation processes in order to reduce costs and focus on core competencies.
·         North America held a major share of the biosimulation market in 2016, commanding over more than half of the market. Due to presence of highly skilled professionals and research infrastructure along with presence of regulatory authorities ensuring patient safety, this market will show promising growth over the forecast period.
·         Asia-Pacific market will exhibit the fastest growth rate during the forecast period due to rapidly improving healthcare infrastructure and growing Healthcare IT expenditure.

Related Reports: 

Global Drug Discovery Technologies Market by Technology Type and End User - Global Industry Analysis and Forecast to 2025:http://www.crystalmarketresearch.com/report/drug-discovery-technologies-market

Clinical Trial Management System Market by End User, Delivery Mode, Type, and Component - Global Industry Analysis and Forecast to 2025:http://www.crystalmarketresearch.com/report/clinical-trial-management-system-market

Synthetic Biology Market by Product, Technology, and Application - Global Industry Analysis and Forecast to 2025:http://www.crystalmarketresearch.com/report/synthetic-biology-market

Biologics Market by Source, Product, Manufacturing, and Disease Category - Global Industry Analysis and Forecast to 2025:http://www.crystalmarketresearch.com/report/biologics-market

Biosimulation market is segmented as follows:
By Product:
·      Services
o   In-house Services
o    Contract/External Services
  • Software
o    Toxicity Prediction Software
o    Molecular Modeling and Simulation Software
o    Trial Design Software
o    PK/PD Modeling and Simulation Software
o    PBPK Modeling and Simulation Software
o    Other Software (QSP, Visualizing and Analytical Software)
By Application:
·         Drug Discovery
o    Target Identification and Optimization
o    Lead Identification and Optimization

·         Drug Development
o    In Patient Validation
o    Preclinical Testing and Clinical Trials

·         Others
By End User:
  • Regulatory Authorities
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutions
  • Contract Research Organization
  • Other End Users
By Region:
  • North America
o    U.S
o    Canada
o    Mexico
  • Europe
o    Germany
o    France
o    UK
o    Italy
o    Spain
o    Rest of Europe
  • Asia-Pacific
o    Japan
o    China
o    Australia
o    India
o    South Korea
o    Rest of Asia-Pacific
  • Rest of the World
o    Brazil
o    South Africa
o    Saudi Arabia
o    Turkey
o    United Arab Emirates
o    Others

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy. 

Contact:

Akhil V.
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282